Rufinamide is a triazole derivative anticonvulsant medication indicated for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome. To ensure the safety and efficacy of this therapeutic… Read more













Rufinamide is a triazole derivative anticonvulsant medication indicated for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome. To ensure the safety and efficacy of this therapeutic agent, pharmaceutical laboratories rely on precise reference standards for rigorous analytical testing and quality control. This category encompasses essential materials required for comprehensive impurity profiling, including pharmacopeial and non-pharmacopeial impurities that may emerge during synthesis or degradation. Additionally, stable isotope labelled compounds, such as deuterium- and nitrogen-15-labelled derivatives, function as critical internal standards for mass spectrometry and other sophisticated quantitative analytical techniques. By utilizing these well-characterized substances, quality control scientists and researchers can accurately validate analytical methods, monitor potential degradation pathways, and comply with strict regulatory requirements for drug substance development and batch release testing.